Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
170
datasets available to search
ShareScore release 0.9.0
Dataset results
170 results for “afatinib;”
Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung
ClinicalTrials.gov study NCT03157089. IPD Sharing: UNDECIDED. Countries: 5. Publications: 2.
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
ClinicalTrials.gov study NCT01466660. IPD Sharing: Not stated. Countries: 14. Publications: 3.
LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib
ClinicalTrials.gov study NCT00711594. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
ClinicalTrials.gov study NCT06302621. IPD Sharing: YES. Countries: 1. Publications: 1.
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation
ClinicalTrials.gov study NCT00949650. IPD Sharing: Not stated. Countries: 25. Publications: 9.
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
ClinicalTrials.gov study NCT01125566. IPD Sharing: Not stated. Countries: 38. Publications: 1.
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
ClinicalTrials.gov study NCT01441596. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Open Label Trial to Explore Safety of Combining Afatinib (BIBW 2992) and Radiotherapy With or Without Temozolomide in Newly Diagnosed Glioblastoma Multiform
ClinicalTrials.gov study NCT00977431. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After Failure of Platinum Based Chemotherapy
ClinicalTrials.gov study NCT02780687. IPD Sharing: Not stated. Countries: 3. Publications: 1.
LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitin
ClinicalTrials.gov study NCT01085136. IPD Sharing: Not stated. Countries: 23. Publications: 1.
BIBW 2992 (Afatinib) in Combination With Pemetrexed in Advanced Solid Tumours
ClinicalTrials.gov study NCT01169675. IPD Sharing: Not stated. Countries: 1. Publications: 1.
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02438722. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation
ClinicalTrials.gov study NCT01953913. IPD Sharing: Not stated. Countries: 5. Publications: 2.
LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations
ClinicalTrials.gov study NCT00525148. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positiv
ClinicalTrials.gov study NCT04795245. IPD Sharing: NO. Countries: 1. Publications: 1.
An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumours
ClinicalTrials.gov study NCT01206816. IPD Sharing: Not stated. Countries: 1. Publications: 1.
LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy
ClinicalTrials.gov study NCT01856478. IPD Sharing: YES. Countries: 8. Publications: 1.
Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
ClinicalTrials.gov study NCT01522768. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Afatinib Osimertinib Sequencing NIS
ClinicalTrials.gov study NCT03370770. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
ClinicalTrials.gov study NCT01345669. IPD Sharing: Not stated. Countries: 29. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.